Mar 2017 Regeneration and mitigation: an opinionated take on NEJM highlights for March 2017 By Marc Herant NEJM Gene therapy for sickle cell disease Typical diseases targeted by gene… Read more
Mar 2017 It’s in the blood: an opinionated take on NEJM highlights for February 2017 By Marc Herant NEJM A knock at the door of a monster franchise Adalimumab (Humira, Abbvie)… Read more